Is Cumberland Pharmaceuticals Inc (CPIX) overvalued? · rev $10.4M
Cumberland Pharmaceuticals Inc (CPIX) is a drug manufacturers - specialty & generic company listed on US.
This page asks whether Cumberland Pharmaceuticals Inc (CPIX) looks expensive on cached numbers — not a short thesis.
Latest reported CPIX revenue for 2024-12-31 was $10.4M. Net income was -$1.9M. Revenue was up 14.9% from 2024-09-30 to 2024-12-31. CPIX currently screens at market cap $86.9M.
CPIX currently screens at market cap $86.9M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CPIX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CPIX stock page for the full model, not this heading.
Not investment advice.